Enviro-Serv Dette/Equité
Quel est le Dette/Equité de Enviro-Serv?
Le Dette/Equité de Enviro-Serv, Inc. est -0.60
Quelle est la définition de Dette/Equité?
Le ratio d'endettement et d'équité est un ratio financier indiquant la proportion relative des capitaux propres et de la dette utilisée pour financer les actifs d'une entreprise.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Dette/Equité des entreprises dans Industrials secteur sur OTC par rapport à Enviro-Serv
Que fait Enviro-Serv?
Enviro-Serv, Inc. provides property maintenance services in the United States. It offers lawn/landscape maintenance and pest control services. The company was formerly known as Transfer Technology International Corp. and changed its name to Enviro-Serv, Inc. in March 2013 to reflect its new strategic corporate direction. Enviro-Serv, Inc. is based in Tampa, Florida.
Entreprises avec dette/equité similaire à Enviro-Serv
- Mechel PJSC a Dette/Equité de -0.79
- Catalyst Biosciences Inc a Dette/Equité de -0.78
- Paratek Pharmaceuticals a Dette/Equité de -0.72
- Vitro Diagnostics a Dette/Equité de -0.67
- Royale a Dette/Equité de -0.63
- McAfee a Dette/Equité de -0.61
- Enviro-Serv a Dette/Equité de -0.60
- Infinity Pharmaceuticals a Dette/Equité de -0.57
- Q BioMed a Dette/Equité de -0.51
- Bang a Dette/Equité de -0.51
- Invitae Corp a Dette/Equité de -0.49
- Inhibitor Therapeutics a Dette/Equité de -0.49
- Biostage a Dette/Equité de -0.44